documents: FDA-2013-D-1275-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-D-1275-0001 | FDA | FDA-2013-D-1275 | General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2014-12-09T05:00:00Z | 2014 | 12 | 2014-12-09T05:00:00Z | 2015-02-10T04:59:59Z | 2015-02-25T03:05:16Z | 2014-28716 | 0 | 0 | 0900006481967c22 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref